BMS

Read more
Giovanni Caforio's photo - Chairman & CEO of BMS

Chairman & CEO

Giovanni Caforio

CEO Approval Rating

80/100

Founded

1858

Status

PublicIndependent CompanyNYSEBMY

Social Links

Annual Revenue
$47B
Employees
32,200
Funding
$0

BMS Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

BMS Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$47B

BMS's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 42.6B. Over the last four quarters, BMS's revenue has decreased by $-55000000. Specifically, in Q1 2022's revenue was $11.6B; in Q4 2021, it was $12B; in Q3 2021, it was $11.6B; in Q2 2021, BMS's revenue was $11.7B.

BMS News

BMS Press Releases

BMS Videos

BMS Headquarters

430 E. 29th Street 14th Floor

New York, New York10016

1-800-332-2056

Driving Directions »

BMS Summary

ABOUT

Overview

BMS is a New York-based biopharmaceutical firm that develops and commercializes medicines for treating patients prevail over serious diseases. BMS was founded in 1858. BMS's headquarters is located in New York, New York, USA 10016. BMS's Chairman & C...

CEO

BMS's Chairman & CEO, Giovanni Caforio, currently has an approval rating of 80%. BMS's primary competitors are Merck, Roche & Gilead.

Website

bms.com

Frequently Asked Questions about BMS

  1. When was BMS founded?

    BMS was founded in 1858
  2. Who is BMS's CEO?

    BMS's CEO is Giovanni Caforio
  3. How much revenue does BMS generate?

    BMS generates $47B in revenue
  4. How much funding does BMS have?

    BMS has historically raised $0 in funding
  5. Where is BMS's headquarters?

    BMS's headquarters is in New York New York, USA
  1. How many employees does BMS have?

    BMS has 32,200 employees
  2. What sector does BMS operate in?

    BMS is in Pharmaceuticals, Biotechnology
  3. Who are BMS's competitors?

    BMS's top competitors are Merck, Roche, Gilead
  4. Who has BMS invested in?

    BMS's has invested in companies such as Owkin, Transition Bio, Sapience Therapeutics

Trending Companies